HomeMCK • NYSE
add
McKesson Corp
Previous close
$555.12
Day range
$556.13 - $560.49
Year range
$373.28 - $566.01
Market cap
72.79B USD
Avg Volume
671.02K
P/E ratio
25.01
Dividend yield
0.44%
Primary exchange
NYSE
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 80.90B | 14.77% |
Operating expense | 2.51B | 31.69% |
Net income | 589.00M | -45.41% |
Net profit margin | 0.73 | -52.29% |
Earnings per share | 7.74 | 12.17% |
EBITDA | 805.00M | -43.27% |
Effective tax rate | -2.94% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.98B | -28.55% |
Total assets | 66.51B | 6.10% |
Total liabilities | 68.19B | 5.27% |
Total equity | -1.68B | — |
Shares outstanding | 131.41M | — |
Price to book | -35.54 | — |
Return on assets | 2.44% | — |
Return on capital | 27.23% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 589.00M | -45.41% |
Cash from operations | 254.00M | -84.77% |
Cash from investing | -180.00M | 56.52% |
Cash from financing | -622.00M | 56.35% |
Net change in cash | -541.00M | -200.56% |
Free cash flow | 75.38M | -95.95% |
About
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees. McKesson had revenues of $276 billion in its fiscal year ending March 31, 2023.
McKesson is based in Irving, Texas, and distributes health care systems, medical supplies and pharmaceutical products. Additionally, McKesson provides extensive network infrastructure for the health care industry; also, it was an early adopter of technologies like bar-code scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the U.S. government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over 1 billion doses across the United States.
As of 2023, McKesson was ranked #9 on the Fortune 500 rankings of the largest United States corporations. Wikipedia
Founded
1833
Website
Employees
45,000